Disease-Free SurvivalPrognosisSurvival RateTreatment OutcomeSurvival AnalysisAntineoplastic Combined Chemotherapy ProtocolsNeoplasm StagingRetrospective StudiesRemission InductionNeoplasm Recurrence, LocalCombined Modality TherapyBreast NeoplasmsKaplan-Meier EstimateCytarabineFollow-Up StudiesDrug Resistance, NeoplasmRecurrenceSalvage TherapyEtoposideTumor Markers, BiologicalChemotherapy, AdjuvantLymphatic MetastasisRadiotherapy, AdjuvantCell SurvivalAntineoplastic AgentsImmunohistochemistryProportional Hazards ModelsLeukemia, Myeloid, AcuteRadiotherapy DosageTime FactorsFluorouracilCarcinoma, Squamous CellNeoplasm InvasivenessCyclophosphamideColorectal NeoplasmsCarcinoma, Ductal, BreastMultivariate AnalysisCarcinomaLiver NeoplasmsAdenocarcinomaImmunoenzyme TechniquesReceptors, EstrogenReceptor, erbB-2Prospective StudiesPredictive Value of TestsGene Expression Regulation, NeoplasticRisk FactorsSurvivalCisplatinNeoplasm MetastasisLung NeoplasmsGraft SurvivalVincristineNeoplasm GradingDoxorubicinDisease ProgressionBone NeoplasmsNeoadjuvant TherapyOvarian NeoplasmsDrug Administration ScheduleCarcinoma, Non-Small-Cell LungChemoradiotherapyCohort StudiesMethotrexateReceptors, ProgesteroneSarcomaHead and Neck NeoplasmsRadiotherapyFree RadicalsLymphoma, Non-HodgkinPrednisoneAge FactorsLymph Node ExcisionActuarial AnalysisBrachytherapyCarboplatinHodgkin DiseaseLymph NodesCarcinoma, HepatocellularNeoplasm ProteinsDrug ResistanceMutationCell Line, TumorNeoplasms, Germ Cell and EmbryonalApoptosisPancreatic NeoplasmsPaclitaxelHematopoietic Stem Cell TransplantationOsteosarcomaTransplantation, AutologousNeoplasm, ResidualTamoxifenAntibodies, MonoclonalTransplantation, HomologousBrain NeoplasmsAntineoplastic Agents, HormonalStomach NeoplasmsRisk AssessmentReverse Transcriptase Polymerase Chain ReactionRectal Neoplasms